28921-30-4 Usage
Purpose
Medication used to treat gout and kidney stones
Mechanism of Action
Reduces the production of uric acid in the body
Enzyme Inhibition
Xanthine oxidase inhibitor
Enzyme Function
Inhibits the conversion of hypoxanthine to xantine and xanthine to uric acid
Effect on Uric Acid
Reduces levels of uric acid in the blood and urine
Prevention
Prevents the formation of gout crystals and kidney stones
Administration
Typically taken orally
Safety and Efficacy
Considered safe and effective when used as directed by a healthcare professional
Check Digit Verification of cas no
The CAS Registry Mumber 28921-30-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,9,2 and 1 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 28921-30:
(7*2)+(6*8)+(5*9)+(4*2)+(3*1)+(2*3)+(1*0)=124
124 % 10 = 4
So 28921-30-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H7ClN2O2S/c11-6-1-3-7(4-2-6)13-9(15)5-8(14)12-10(13)16/h1-4H,5H2,(H,12,14,16)
28921-30-4Relevant articles and documents
Chemical modification of plant alkaloids. 2. Reaction of cotarnine with barbituric acid derivatives and structure of 5-dihydrocotarnylbarbituric acids
Krasnov,Kartsev,Yurova
, p. 543 - 550 (2007/10/03)
The reaction of barbituric acid and its N-substituted derivatives and 2-thio analogs with cotarnine forms 5-(4-methoxy-6-methyl-5,6,7,8-tetrahydro-2H-1,3-methylenedioxy-[4,5-g]isoquinolinyl-1)barbituric acids, a new class of zwitter-ions, the structure of which was studied by 1H and 13C NMR spectroscopy and mass spectrometry. The prepared compounds exist in solution as stable intermolecular associates and have a complicated H-bonded structure.